Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023

We estimated influenza vaccine effectiveness (IVE) in preventing outpatient and hospitalized cases in the 2022–2023 season. A test-negative design included a representative sample of outpatients and all hospitalized patients with influenza-like illness (ILI) from October 2022 to May 2023 in Navarre,...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Baz, Iván, Fernández-Huerta, Miguel, Navascués, Ana, Pozo, Francisco, Trobajo-Sanmartín, Camino, Casado, Itziar, Echeverria, Aitziber, Ezpeleta, Carmen, Castilla, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534462/
https://www.ncbi.nlm.nih.gov/pubmed/37766154
http://dx.doi.org/10.3390/vaccines11091478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534462/
https://www.ncbi.nlm.nih.gov/pubmed/37766154
http://dx.doi.org/10.3390/vaccines11091478

Ejemplares similares